1. Home
  2. OSIS vs FOLD Comparison

OSIS vs FOLD Comparison

Compare OSIS & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OSIS
  • FOLD
  • Stock Information
  • Founded
  • OSIS 1987
  • FOLD 2002
  • Country
  • OSIS United States
  • FOLD United States
  • Employees
  • OSIS N/A
  • FOLD N/A
  • Industry
  • OSIS Industrial Machinery/Components
  • FOLD Biotechnology: Pharmaceutical Preparations
  • Sector
  • OSIS Technology
  • FOLD Health Care
  • Exchange
  • OSIS Nasdaq
  • FOLD Nasdaq
  • Market Cap
  • OSIS 3.4B
  • FOLD 2.9B
  • IPO Year
  • OSIS 1997
  • FOLD 2007
  • Fundamental
  • Price
  • OSIS $194.19
  • FOLD $6.83
  • Analyst Decision
  • OSIS Strong Buy
  • FOLD Strong Buy
  • Analyst Count
  • OSIS 6
  • FOLD 9
  • Target Price
  • OSIS $206.50
  • FOLD $17.00
  • AVG Volume (30 Days)
  • OSIS 227.4K
  • FOLD 3.9M
  • Earning Date
  • OSIS 04-28-2025
  • FOLD 05-08-2025
  • Dividend Yield
  • OSIS N/A
  • FOLD N/A
  • EPS Growth
  • OSIS 18.05
  • FOLD N/A
  • EPS
  • OSIS 7.78
  • FOLD N/A
  • Revenue
  • OSIS $1,650,140,000.00
  • FOLD $528,294,999.00
  • Revenue This Year
  • OSIS $12.56
  • FOLD $21.83
  • Revenue Next Year
  • OSIS $5.14
  • FOLD $22.16
  • P/E Ratio
  • OSIS $24.95
  • FOLD N/A
  • Revenue Growth
  • OSIS 20.69
  • FOLD 32.29
  • 52 Week Low
  • OSIS $126.57
  • FOLD $6.20
  • 52 Week High
  • OSIS $220.00
  • FOLD $12.65
  • Technical
  • Relative Strength Index (RSI)
  • OSIS 52.80
  • FOLD 32.01
  • Support Level
  • OSIS $185.44
  • FOLD $6.20
  • Resistance Level
  • OSIS $196.13
  • FOLD $6.95
  • Average True Range (ATR)
  • OSIS 10.77
  • FOLD 0.43
  • MACD
  • OSIS 0.80
  • FOLD -0.04
  • Stochastic Oscillator
  • OSIS 85.83
  • FOLD 29.86

About OSIS OSI Systems Inc. (DE)

OSI Systems Inc is a designer and manufacturer of electronic systems and components for businesses in the homeland security, healthcare, defense, and aerospace markets. The firm is organized in three business segments: Security, which derives maximum revenue, provides security and inspection systems; Healthcare, which provides patient monitoring, diagnostic, cardiology, ventilation systems and defibrillators; and Optoelectronics and Manufacturing, which provides specialized electronic components and manufacturing services for the Security and Healthcare segments and external original equipment manufacturers. Majority of the firm's revenue is generated in the United States, and the rest from Mexico, Europe, the Middle East, and Africa, and the Asia Pacific regions.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: